GBD 2021: Global, Regional, and National Burden of Disorders Affecting the Nervous System, 1990–2021
2024
This article from the Lancet analyzes the global, regional, and national burden of disorders impacting the nervous system using data from the Global Burden of Disease (GBD) Study 2021. The paper seeks to understand how a diverse set of disorders, including neurodevelopmental disorders and emergent conditions, such as cognitive impairment as a result of COVID-19 illness– result in nervous system health loss. The paper provides estimates of mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life years (DALYs) for 37 conditions and risk factors in 204 countries and territories from 1990 to 2021.
Led by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, GBD is a global effort with researchers from over 150 countries and territories. IHME and other partnering organizations have developed numerous resources to disseminate and visualize the findings of the GBD studies, data visualizations and interactives, country profiles, policy reports, research articles, infographics, and the GBD Results Tool, which allows users to search GBD data.
GBD 2021: Global, Regional, and National Burden of Disorders Affecting the Nervous System, 1990–2021
Source:
GBD 2021 Nervous System Disorders Collaborators. Global, Regional, and National Burden of Disorders Affecting the Nervous System, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021. The Lancet Neurology 2024. DOI: https://doi.org/10.1016/S1474-4422(24)00038-3.